Mark Neumann

Insider Reports History

Entity
Individual
Location
C/O Intra Cellular Therapies, Inc., 430 East 29 Th Street, New York, NY
Signature
/s/ John P. Condon, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Neumann:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Intra-Cellular Therapies, Inc. EVP, Chief Commercial Officer Common Stock 29.7K $2.23M $75.08 Aug 16, 2024 Direct
Intra-Cellular Therapies, Inc. EVP, Chief Commercial Officer Restricted Stock Units 7.35K $490K $66.70 Mar 10, 2024 Direct
Intra-Cellular Therapies, Inc. EVP, Chief Commercial Officer Stock Option (right to buy) 0 Aug 16, 2024 Direct

Insider Reports Filed by Mark Neumann

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ITCI Intra-Cellular Therapies, Inc. Aug 16, 2024 3 -$715K 4 Aug 20, 2024 EVP, Chief Commercial Officer
ITCI Intra-Cellular Therapies, Inc. Mar 7, 2024 7 -$1.36M 4 Mar 11, 2024 EVP, Chief Commercial Officer
ITCI Intra-Cellular Therapies, Inc. Mar 6, 2024 2 $0 4 Mar 8, 2024 EVP, Chief Commercial Officer
ITCI Intra-Cellular Therapies, Inc. Mar 1, 2024 1 $0 4 Mar 5, 2024 EVP, Chief Commercial Officer
ITCI Intra-Cellular Therapies, Inc. Feb 23, 2024 6 -$554K 4 Feb 27, 2024 EVP, Chief Commercial Officer
ITCI Intra-Cellular Therapies, Inc. Feb 1, 2024 3 -$796K 4 Feb 5, 2024 EVP, Chief Commercial Officer
ITCI Intra-Cellular Therapies, Inc. Nov 6, 2023 4 -$1.72M 4 Nov 8, 2023 EVP, Chief Commercial Officer
ITCI Intra-Cellular Therapies, Inc. Aug 7, 2023 3 -$2.22M 4 Aug 9, 2023 EVP, Chief Commercial Officer
ITCI Intra-Cellular Therapies, Inc. Mar 28, 2023 2 -$847K 4 Mar 30, 2023 EVP, Chief Commercial Officer
ITCI Intra-Cellular Therapies, Inc. Mar 9, 2023 7 -$540K 4 Mar 13, 2023 EVP, Chief Commercial Officer
ITCI Intra-Cellular Therapies, Inc. Mar 6, 2023 1 $0 4 Mar 8, 2023 EVP, Chief Commercial Officer
ITCI Intra-Cellular Therapies, Inc. Mar 1, 2023 1 -$362K 4 Mar 3, 2023 EVP, Chief Commercial Officer
ITCI Intra-Cellular Therapies, Inc. Feb 23, 2023 3 -$191K 4 Feb 27, 2023 EVP, Chief Commercial Officer
ITCI Intra-Cellular Therapies, Inc. Feb 18, 2023 5 -$183K 4 Feb 22, 2023 EVP, Chief Commercial Officer
ITCI Intra-Cellular Therapies, Inc. Apr 8, 2022 5 -$4.46M 4 Apr 8, 2022 EVP, Chief Commercial Officer
ITCI Intra-Cellular Therapies, Inc. Mar 10, 2022 2 $0 4 Mar 14, 2022 EVP, Chief Commercial Officer
ITCI Intra-Cellular Therapies, Inc. Feb 23, 2022 5 -$413K 4 Feb 25, 2022 EVP, Chief Commercial Officer
ITCI Intra-Cellular Therapies, Inc. Feb 18, 2022 4 -$616K 4 Feb 23, 2022 EVP, Chief Commercial Officer
ITCI Intra-Cellular Therapies, Inc. Jan 8, 2022 5 -$854K 4 Jan 11, 2022 EVP, Chief Commercial Officer
ITCI Intra-Cellular Therapies, Inc. Oct 15, 2021 6 -$550K 4 Oct 19, 2021 EVP, Chief Commercial Officer